- Home
- INM vs CPHI Comparison
INM vs CPHI Comparison
Compare INM & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CPHI
- Stock Information
- Founded
- INM 1981
- CPHI N/A
- Country
- INM Canada
- CPHI China
- Employees
- INM N/A
- CPHI N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- CPHI Health Care
- Exchange
- INM Nasdaq
- CPHI Nasdaq
- Market Cap
- INM 5.0M
- CPHI 4.7M
- IPO Year
- INM N/A
- CPHI N/A
- Fundamental
- Price
- INM $2.07
- CPHI $1.78
- Analyst Decision
- INM
- CPHI
- Analyst Count
- INM 0
- CPHI 0
- Target Price
- INM N/A
- CPHI N/A
- AVG Volume (30 Days)
- INM 116.2K
- CPHI 14.2K
- Earning Date
- INM 11-13-2025
- CPHI 11-12-2025
- Dividend Yield
- INM N/A
- CPHI N/A
- EPS Growth
- INM N/A
- CPHI N/A
- EPS
- INM N/A
- CPHI N/A
- Revenue
- INM $4,942,633.00
- CPHI $4,396,201.00
- Revenue This Year
- INM N/A
- CPHI N/A
- Revenue Next Year
- INM N/A
- CPHI N/A
- P/E Ratio
- INM N/A
- CPHI N/A
- Revenue Growth
- INM 7.50
- CPHI N/A
- 52 Week Low
- INM $1.72
- CPHI $1.20
- 52 Week High
- INM $8.27
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- CPHI 46.82
- Support Level
- INM $2.04
- CPHI $1.64
- Resistance Level
- INM $2.26
- CPHI $1.93
- Average True Range (ATR)
- INM 0.14
- CPHI 0.08
- MACD
- INM -0.01
- CPHI -0.03
- Stochastic Oscillator
- INM 10.44
- CPHI 38.89
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.